103 related articles for article (PubMed ID: 10983695)
21. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
[TBL] [Abstract][Full Text] [Related]
22. [Lack of association between VNTR polymorphism of DAT gene and schizophrenia].
Hauser J; Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Twardowska K; Rybakowski JK
Psychiatr Pol; 2002; 36(3):403-12. PubMed ID: 12149916
[TBL] [Abstract][Full Text] [Related]
23. Dopamine transporter gene polymorphism and alcoholism.
Muramatsu T; Higuchi S
Biochem Biophys Res Commun; 1995 Jun; 211(1):28-32. PubMed ID: 7779096
[TBL] [Abstract][Full Text] [Related]
24. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.
Mössner R; Henneberg A; Schmitt A; Syagailo YV; Grässle M; Hennig T; Simantov R; Gerlach M; Riederer P; Lesch KP
Mol Psychiatry; 2001 May; 6(3):350-2. PubMed ID: 11326308
[TBL] [Abstract][Full Text] [Related]
25. Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease.
Paus S; Seeger G; Brecht HM; Köster J; El-Faddagh M; Nöthen MM; Klockgether T; Wüllner U
Mov Disord; 2004 Jun; 19(6):705-7. PubMed ID: 15197713
[No Abstract] [Full Text] [Related]
26. DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease.
Purcaro C; Vanacore N; Moret F; Di Battista ME; Rubino A; Pierandrei S; Lucarelli M; Meco G; Fattapposta F; Pascale E
Neurosci Lett; 2019 Jan; 690():83-88. PubMed ID: 30316985
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphism of the 3' VNTR region of the human dopaminergic function gene DAT1 (human dopamine transporter gene) in the Mongolian population.
Nakatome M; Honda K; Tun Z; Kato Y; Harihara S; Omoto K; Misawa S; Gerelsaikhan T; Nyamkhishig S; Dashnyam B; Batsuuri J; Wakasugi C
Hum Biol; 1996 Aug; 68(4):509-15. PubMed ID: 8754257
[TBL] [Abstract][Full Text] [Related]
28. Variability and validity of polymorphism association studies in Parkinson's disease.
Tan EK; Khajavi M; Thornby JI; Nagamitsu S; Jankovic J; Ashizawa T
Neurology; 2000 Aug; 55(4):533-8. PubMed ID: 10953187
[TBL] [Abstract][Full Text] [Related]
29. Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode.
Inada T; Sugita T; Dobashi I; Inagaki A; Kitao Y; Matsuda G; Kato S; Takano T; Yagi G; Asai M
Am J Med Genet; 1996 Jul; 67(4):406-8. PubMed ID: 8837710
[TBL] [Abstract][Full Text] [Related]
30. Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration.
Storch A; Ludolph AC; Schwarz J
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1267-86. PubMed ID: 15480838
[TBL] [Abstract][Full Text] [Related]
31. Genotypic association between dopamine transporter gene polymorphisms and schizophrenia.
Persico AM; Macciardi F
Am J Med Genet; 1997 Feb; 74(1):53-7. PubMed ID: 9034007
[TBL] [Abstract][Full Text] [Related]
32. Association study of a functional variant in intron 8 of the dopamine transporter gene and migraine susceptibility.
McCallum LK; Fernandez F; Quinlan S; Macartney DP; Lea RA; Griffiths LR
Eur J Neurol; 2007 Jun; 14(6):706-7. PubMed ID: 17539957
[TBL] [Abstract][Full Text] [Related]
33. No evidence of association between a dopamine transporter gene polymorphism (1215A/G) and Parkinson's disease.
Kimura M; Matsushita S; Arai H; Takeda A; Higuchi S
Ann Neurol; 2001 Feb; 49(2):276-7. PubMed ID: 11220753
[No Abstract] [Full Text] [Related]
34. A cloned dopamine transporter. Potential insights into Parkinson's disease pathogenesis.
Uhl GR; Kitayama S
Adv Neurol; 1993; 60():321-4. PubMed ID: 8380524
[No Abstract] [Full Text] [Related]
35. [The dopamine transporter: characterization and physiopathologic implications].
Thibaut F; Vaugeois JM; Petit M
Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
[TBL] [Abstract][Full Text] [Related]
36. Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different.
Vandenbergh DJ; Bennett CJ; Grant MD; Strasser AA; O'Connor R; Stauffer RL; Vogler GP; Kozlowski LT
Nicotine Tob Res; 2002 Aug; 4(3):333-40. PubMed ID: 12215242
[TBL] [Abstract][Full Text] [Related]
37. Dopamine transporter mutants selectively enhance MPP+ transport.
Kitayama S; Wang JB; Uhl GR
Synapse; 1993 Sep; 15(1):58-62. PubMed ID: 8310426
[TBL] [Abstract][Full Text] [Related]
38. Variation at the serotonin transporter gene influences susceptibility to bipolar affective puerperal psychosis.
Coyle N; Jones I; Robertson E; Lendon C; Craddock N
Lancet; 2000 Oct; 356(9240):1490-1. PubMed ID: 11081536
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease.
Wang J; Zhao C; Chen B; Liu ZL
Neurosci Lett; 2004 Jan; 355(3):193-6. PubMed ID: 14732464
[TBL] [Abstract][Full Text] [Related]
40. Dopamine transporter genetic variants and pesticides in Parkinson's disease.
Ritz BR; Manthripragada AD; Costello S; Lincoln SJ; Farrer MJ; Cockburn M; Bronstein J
Environ Health Perspect; 2009 Jun; 117(6):964-9. PubMed ID: 19590691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
